ARCHIVES

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

ODAC Vote On CPT-11 Changes Standard Of Care For Advanced Colorectal Cancer.

March 24, 2000

Montana Drug Salesman Pleads Guilty to Selling Counterfeit Avastin

July 25, 2013

Tobacco Control: Cigarette Price Hikes Reduce Smoking, Study Confirms

August 7, 1998

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

February 11, 2011

NIH Dedicates Louis Stokes Laboratories; Royston Retires As Kimmel Center President.

June 22, 2001

Also MQSA should require mammography facilities to gather data on interpretation, cancer policy board committee says.

May 27, 2005